What is MaxCyte's operating lease liabilities?

MaxCyte (MXCT) reported operating lease liabilities of -$456K in Q1 2026.

How has MaxCyte's operating lease liabilities changed year-over-year?

MaxCyte's operating lease liabilities decreased by 64.0% year-over-year, from -$278K to -$456K.

What is the long-term trend for MaxCyte's operating lease liabilities?

Over 3 years (2021 to 2025), MaxCyte's operating lease liabilities has grown at a -33.2% compound annual growth rate (CAGR), from $3.87M to -$1.16M.

MaxCyte MXCT Operating lease liabilities

Operating lease liabilities at other companies

Ginkgo BioworksDNA

——

Immix Biopharma, Inc.IMMX

——

RepligenRGEN

——

Prime MedicinePRME

——

BioSig Technologies, Inc.STEX

——

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's operating lease liabilities?: MaxCyte (MXCT) reported operating lease liabilities of -$456K in Q1 2026.
How has MaxCyte's operating lease liabilities changed year-over-year?: MaxCyte's operating lease liabilities decreased by 64.0% year-over-year, from -$278K to -$456K.
What is the long-term trend for MaxCyte's operating lease liabilities?: Over 3 years (2021 to 2025), MaxCyte's operating lease liabilities has grown at a -33.2% compound annual growth rate (CAGR), from $3.87M to -$1.16M.